Commissioning Policy: South Warwickshire CCG (SWCCG)

Similar documents
Swindon Joint Strategic Needs Assessment Bulletin

Corporate Governance Code for Funds: What Will it Mean?

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

DRAFT Policy for the Management of Ear Wax

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

The data refer to persons aged between 15 and 54.

US Public Health Service Clinical Practice Guidelines for PrEP

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Referral Criteria: Inflammation of the Spine Feb

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

WCPT awards programme 2015

A. Catalonia World Health Organization Demonstration Project

CLINICAL MEDICAL POLICY

World Confederation for Physical Therapy Congress , May Singapore

Code of Conduct for Employees

Hospital Preparedness Checklist

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Summary Report. Introduction and setting the scene Autilia Newton, Public Health England, Health & Justice Acting Deputy Director

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

CFS Private Sector modalities

Methadone Maintenance Treatment for Opioid Dependence

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Division Key Points MMWR Updates February 20, 2014

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

Assessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Palliative Medicine Specialist

SCHEDULE 2 THE SERVICES

Medical Director of Palliative Care INFORMATION PACK

Study Design Open, three arm-stratified, non-randomized, prospective, multicentric study

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Commissioning Policy. The Use of Acupuncture in the Management of Musculoskeletal Pain July 2014

VCCC Research and Education Lead for Breast Cancer

Position Title Diabetes Educator Program / Funding Stream Primary Health Care

Full-time or part-time to a minimum of 0.8FTE (30 hours per week) Job Reference: CLS00161

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

FDA Dietary Supplement cgmp

Completing the NPA online Patient Safety Incident Report form: 2016

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Strategic Plan Publication No: EO-SP

Attachment 3. Efforts to Address the Opioid Epidemic in Clark County

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

Building Code 101 OWMC November 20, Ministry of Municipal Affairs and Housing

Frontier School of Innovation District Wellness Policy

Related Policies None

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

The principles of evidence-based medicine

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

ARLA FOOD FOR HEALTH 4 th ANNUAL CALL FOR EXPRESSIONS OF INTEREST

Code of employment practice on infant feeding

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation

British Sign Language (BSL) Plan October 2018 Scottish Charity Regulator

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

Annex III. Amendments to relevant sections of the Product Information

Campus Climate Survey

Ontario 2018 provincial election issues backgrounder

Reliability and Validity Plan 2017

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Catherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support

Widening of funding restrictions for rituximab and eltrombopag

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE

TELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT

Diabetes Canada Pre-Budget Consultation Submission. Standing Committee on Finance and Economic Affairs. Government of Ontario.

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Where do we stand today?

Programme of Learning. Physical Education. Key Stage 4 Year 10 BTEC Sport

AUXILIARY AID AND SERVICES PLAN January 2017, Revised- All Rights Reserved

2017 Optum, Inc. All rights reserved BH1124_112017

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

Pain relief after surgery

Catherine Worthingham Fellows of the APTA Instructions for Nominators

Frequently Asked Questions: IS RT-Q-PCR Testing

S.K.J Construction Ltd Groundwork & Civil Engineering

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Meaningful Use Roadmap Stage Edition Eligible Hospitals

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

SUFFOLK COUNTY COUNCIL. Anti- Social Behaviour Act Penalty Notice. Code of conduct

Guidelines for the Admission of Children and Young People with an Eating Disorder

2017 CMS Web Interface

CDC Influenza Division Key Points November 7, 2014

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

ALCAT FREQUENTLY ASKED QUESTIONS

Vaccine Impact Modelling Consortium

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

Diabetes: HbA1c Poor Control (NQF 0059)

DISTRIBUTION: ORGANIZATION WIDE APPROVED BY: VP COMPLIANCE

Evaluation of Hunter & New England HealthPathways

Smoking Cessation Improvement in SFHN Primary Care,

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

PET FORM Planning and Evaluation Tracking ( Assessment Period)

Safety of HPV vaccination: A FIGO STATEMENT

Transcription:

Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding Request (IFR) Department at NHS Cventry and Rugby CCG. Applicatins can be made by secndary care t crccg.ardenifr@nhs.net in line with the Prir Apprval Prcess. 1 It is recmmended that FreeStyle Libre shuld nly be used fr peple with Type 1 diabetes, aged 4 and abve, attending specialist Type 1 care using multiple daily injectins r insulin pump therapy, wh have been assessed by the specialist clinician and deemed t meet tw r mre f the belw criteria. Patients wh undertake intensive mnitring, 8 r mre times daily (and fr whm this frequency f mnitring is deemed clinically apprpriate); AND at least ne f the fllwing Thse wh meet the current NICE criteria fr insulin pump therapy (HbA1c >8.5% (69.4mml/ml) r disabling hypglycaemia as described in NICE TA 151) where a successful trial f FreeStyle Libre may avid the need fr pump therapy; Thse wh have recently develped impaired awareness f hypglycaemia. It is nted that fr hypglycaemia unawareness, NICE recmmend cntinuus glucse mnitring with alarms and FreeStyle Libre des nt currently have that functin; Frequent admissins (>2 per year) with DKA r hypglycaemia; Thse wh require third parties t carry ut mnitring and where cnventinal bld testing is nt pssible; Additinally amng children and yung peple aged 4 and ver with Type 1 diabetes, the fllwing grups may be apprpriate fr a FreeStyle Libre trial despite ptimised use f insulin therapy and cnventinal bld glucse mnitring: Children and yung peple wh undertake high levels f physical activity (fr example, sprt at a reginal, natinal r internatinal level). Children and yung peple wh have c-mrbidities (fr example anrexia nervsa) r wh are receiving treatments (fr example 1 www.suthwarwickshireccg.nhs.uk/abut-us/publicatins-and-plicies/cmmissining-plicies Suth Warwickshire Clinical Cmmissining Grup Freestyle Libre Glucse Mnitring plicy Final Versin May 18 1

crticsterids) that can make bld glucse cntrl difficult. Children and yung peple wh cntinue t have hyperglycaemia despite insulin adjustment and additinal supprt. All patients (r carers) must be willing t undertake training in the use f FreeStyle Libre and cmmit t nging regular fllw-up and mnitring (including remte fllw-up where this is ffered). Adjunct bld testing strips shuld be prescribed accrding t lcally agreed best value guidelines with an expectatin that demand/frequency f supply will be reduced. Review and cntinuatin Fr patients meeting the criteria FreeStyle Libre shuld be initially prescribed fr a maximum 6 mnth perid during which time data shuld be cllected n the belw indicatrs. 1. Reductins in severe/nn-severe hypglycaemia 2. Reversal f impaired awareness f hypglycaemia 3. Episdes f diabetic ketacidsis 4. Admissins t hspital 5. Changes in HbA1c 6. Testing strip usage 7. Quality f Life changes using validated rating scales. 8. Cmmitment t regular scans and their use in self-management. A review shuld take place with the respnsible clinician at the end f the initial trial perid; if n imprvement is demnstrated in ne r mre f these areas the use f Freestyle Libre shuld discntinued and an alternative methd f mnitring used. Expectatins regarding patient cmpliance and cntinuatin criteria shuld be made clear t the patient befre initiatin f the trial perid. Patients wh have btained a Flash Cntinuus Glucse Mnitring System thrugh clinical trials r private treatment, r wh have been self-funding, must demnstrate that they satisfied the prescribing criteria when they cmmenced the use f the Flash Cntinuus Glucse Mnitring System as well as meet the cntinuatin criteria, t receive Flash Cntinuus Glucse Mnitring System n NHS prescriptin. Equality Impact See EIA attached Suth Warwickshire Clinical Cmmissining Grup Freestyle Libre Glucse Mnitring plicy Final Versin May 18 2

VERSION CONTROL Versin 1.0 Ratified by Gverning Bdy Date ratified 23 rd May 2018 Name f riginatr/authr Jint CCG Clinical Cmmissining Plicy Develpment Grup Name f respnsible Clinical Quality and Gvernance Cmmittee cmmittee Date issued 25 th May 2018 Review date May 2019 Suth Warwickshire Clinical Cmmissining Grup Freestyle Libre Glucse Mnitring plicy Final Versin May 18 3

Equality Impact Assessment (EIA) Plicy/Service FreeStyle Libre Flash Cntinuus Glucse Mnitring System Persn cmpleting EIA Jint Plicy Develpment Grup Date f EIA February 2018 Accuntable CCG Lead Anna Hargrave NHS Suth Warwickshire Clinical Cmmissining Grup Aim f Wrk The Public Sectr Equality Duty (PSED) requires us t eliminate discriminatin, advance equality f pprtunity, and fster gd relatins with prtected grups. This EIA assesses the impact f the plicy n prtected grups. Prtected Grup Likely t be a differential impact? Prtected Grup Likely t be a differential impact? Age Yes Race Yes Disability Yes Religin r belief N Gender reassignment N Sex N Marriage and civil partnership N Sexual rientatin N Pregnancy and maternity N Describe any ptential r knwn adverse impacts r barriers fr prtected/vulnerable grups and what actins will be taken (if any) t mitigate. If there are n knwn adverse impacts, please explain. Since CCGs perate within finite budgetary cnstraints the plicies detailed in this dcument make explicit the need fr the CCG t priritise resurces and prvide interventins with the greatest prven health gain. The intentin is t ensure equity and fairness in respect f access t NHS funding fr interventins and t ensure that interventins are prvided within the cntext f the needs f the verall ppulatin and the evidence f clinical and cst effectiveness. The plicy prvides a cnsistent clinically based criteria fr decisin making, benefitting patients within the CCG area by prviding cnsistency and equity f service prvisin. The plicy prvides an avenue thrugh the Individual Funding Requests plicy t seek funding in exceptinal clinical circumstances. The impact f this plicy has been discussed at length by the Cventry and Warwickshire Jint Plicy Develpment grup and all prtected characteristics and Human Rights values given due regard and nly patient demgraphic issues that culd impact n individual risk and/r clinical effectiveness were taken int accunt when reaching a 4

decisin. All three lcal Clinical Cmmissining Grups, Cventry and Rugby CCG; Suth Warwickshire CCG and Warwickshire Nrth CCG, have a cmmissining plicy n FreeStyle Libre. Age: This plicy relates nly t child ver 4 years f age. Disability: This plicy is expected t have a psitive impact in terms f imprving the ability f peple with learning difficulties and certain mental health cnditins t manage their diabetes, with ptential cnsequences f reducing inequities in health utcmes related t Type 1 diabetes. Race: Type 1 diabetes tends t be mre prevalent in peple f Eurpean rigin, s there is ptential fr verrepresentatin f this grup in terms f uptake f this plicy (cmpared t the general ppulatin distributin by ethnicity). This plicy will be applied equally t all patients with diabetes Type 1 irrespective f ethnic backgrund. Please summarise where further actin is required and when the prjects/decisin will be reviewed. The plicy will be reviewed 12 mnths after ratificatin by Gverning Bdy, when evidence n patient utcmes will be reviewed. 5